Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

ADC Therapeutics expands team

Appointments preceed its first antibody drug conjugate trials

- PMLiVE

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Will gain access to the biopharma's portfolio of viral infection candidates

- PMLiVE

Cancer pain: opioids set to dominate

But much work is being done to improve the delivery systems of these drugs

- PMLiVE

Good practice in blood clot care recognised at awards

First winners of QiC Anticoagulation programme announced

- PMLiVE

EMA to review experimental Ebola drugs

Response comes as death-toll tops 3,000

- PMLiVE

PD1 drugs could end ‘decades of silence’ in bladder cancer therapy

Merck's Keytruda and Roche antibody showing promise

- PMLiVE

Janssen, AZ and Roche at ESMO

Companies present promising data on new cancer drugs

- PMLiVE

Amag buys into maternal health business

Will acquire female health specialist Lumara Health

- PMLiVE

Alacrita appoints Stuart Hendry as associate partner

Joins from medical device firm Sphere Medical

Daiichi Sankyo logo

Japan’s Daiichi Sankyo pays $410m for Ambit Biosciences

Gains rights to cancer drug quizartinib

- PMLiVE

EMA wants to embed patient viewpoint within drug assessment

Will pilot CHMP benefit-risk evaluation project

Gilead Sciences

Gilead’s hep C combination Harvoni recommended for EU approval

CHMP backs combination of Sovaldi and ledipasvir

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links